| 000 | 01738 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515153837.0 | ||
| 264 | 0 | _c20090916 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1937-335X | ||
| 024 | 7 |
_a10.1089/ten.tea.2008.0316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHakala, Heidi | |
| 245 | 0 | 0 |
_aComparison of biomaterials and extracellular matrices as a culture platform for multiple, independently derived human embryonic stem cell lines. _h[electronic resource] |
| 260 |
_bTissue engineering. Part A _cJul 2009 |
||
| 300 |
_a1775-85 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiocompatible Materials _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Shape _xdrug effects |
| 650 | 0 | 4 | _aCell-Free System |
| 650 | 0 | 4 |
_aCollagen _xpharmacology |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xcytology |
| 650 | 0 | 4 |
_aExtracellular Matrix _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaminin _xpharmacology |
| 650 | 0 | 4 |
_aOctamer Transcription Factor-3 _xgenetics |
| 650 | 0 | 4 |
_aProteoglycans _xpharmacology |
| 650 | 0 | 4 | _aSerum |
| 700 | 1 | _aRajala, Kristiina | |
| 700 | 1 | _aOjala, Marisa | |
| 700 | 1 | _aPanula, Sarita | |
| 700 | 1 | _aAreva, Sami | |
| 700 | 1 | _aKellomäki, Minna | |
| 700 | 1 | _aSuuronen, Riitta | |
| 700 | 1 | _aSkottman, Heli | |
| 773 | 0 |
_tTissue engineering. Part A _gvol. 15 _gno. 7 _gp. 1775-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/ten.tea.2008.0316 _zAvailable from publisher's website |
| 999 |
_c18581799 _d18581799 |
||